# FrontView REIT, Inc.: financial statements, quarterly

FVR · NYSE · CIK 1988494 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fvr.md) · [Financials](/companies/fvr/financials.md) · [Filings](/companies/fvr/filings.md) · [Insiders](/companies/fvr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fvr/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [15.3](/filings/0000950170-25-072774.md) | [14.6](/filings/0000950170-25-108893.md) | [14.5](/filings/0001193125-25-280175.md) | [15.2](/filings/0001193125-26-072181.md) | [0.1](/filings/0001193125-26-211875.md) | [0.1](/filings/0001193125-26-338354.md) | [16.8](/filings/0001193125-25-280175.md) | [16.5 d](/filings/0001193125-26-072181.md) | [0.3](/filings/0001193125-26-211875.md) | [0.2](/filings/0001193125-26-338354.md) |
| Operating income | $m | not reported | not reported | not reported | [(4.8)](/filings/0001193125-26-072181.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [6.7](/filings/0000950170-25-072774.md) | [6.6](/filings/0000950170-25-108893.md) | [6.5](/filings/0001193125-25-280175.md) | [3.5](/filings/0001193125-26-072181.md) | [4.5](/filings/0001193125-26-211875.md) | [4.6](/filings/0001193125-26-338354.md) | [4.6](/filings/0001193125-25-280175.md) | [4.3 d](/filings/0001193125-26-072181.md) | [4.2](/filings/0001193125-26-211875.md) | [4.2](/filings/0001193125-26-338354.md) |
| Income tax | $m | [0.2](/filings/0000950170-25-072774.md) | [0.1](/filings/0000950170-25-108893.md) | [0.1](/filings/0001193125-25-280175.md) | [0.2](/filings/0001193125-26-072181.md) | [0.1](/filings/0001193125-26-211875.md) | [0.2](/filings/0001193125-26-338354.md) | [0.1](/filings/0001193125-25-280175.md) | [0.0 d](/filings/0001193125-26-072181.md) | [0.1](/filings/0001193125-26-211875.md) | [0.1](/filings/0001193125-26-338354.md) |
| Net income | $m | [(2.5)](/filings/0001193125-25-280175.md) | [(2.2)](/filings/0001193125-25-280175.md) | [(2.4)](/filings/0001193125-25-280175.md) | [(3.0)](/filings/0001193125-26-072181.md) | [(0.8)](/filings/0001193125-26-211875.md) | [(2.9)](/filings/0001193125-26-338354.md) | [4.0](/filings/0001193125-25-280175.md) | [(4.1) d](/filings/0001193125-26-072181.md) | [0.3](/filings/0001193125-26-211875.md) | [1.2](/filings/0001193125-26-338354.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | [(0.19)](/filings/0001193125-26-072181.md) | [(0.06)](/filings/0001193125-26-211875.md) | [(0.16)](/filings/0001193125-26-338354.md) | [0.19](/filings/0001193125-25-280175.md) | not reported | [0.00](/filings/0001193125-26-211875.md) | [0.03](/filings/0001193125-26-338354.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | [(0.19)](/filings/0001193125-26-072181.md) | [(0.06)](/filings/0001193125-26-211875.md) | [(0.16)](/filings/0001193125-26-338354.md) | [0.19](/filings/0001193125-25-280175.md) | not reported | [0.00](/filings/0001193125-26-211875.md) | [0.03](/filings/0001193125-26-338354.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.0](/filings/0000950170-24-127114.md) | not reported | not reported | [0.0](/filings/0000950170-24-127114.md) | [5.1](/filings/0001193125-26-072181.md) | [3.3](/filings/0000950170-25-072774.md) | [8.4](/filings/0000950170-25-108893.md) | [19.6](/filings/0001193125-25-280175.md) | [13.5](/filings/0001193125-26-338354.md) | [9.3](/filings/0001193125-26-211875.md) | [6.0](/filings/0001193125-26-338354.md) |
| Total assets | $m | not reported | [772](/filings/0000950170-25-042774.md) | not reported | not reported | [0.0](/filings/0000950170-24-127114.md) | [822](/filings/0001193125-26-072181.md) | [861](/filings/0000950170-25-072774.md) | [857](/filings/0000950170-25-108893.md) | [847](/filings/0001193125-25-280175.md) | [854](/filings/0001193125-26-338354.md) | [870](/filings/0001193125-26-211875.md) | [900](/filings/0001193125-26-338354.md) |
| Total liabilities | $m | not reported | [471](/filings/0000950170-25-042774.md) | not reported | not reported | not reported | [299](/filings/0001193125-26-072181.md) | [345](/filings/0000950170-25-072774.md) | [353](/filings/0000950170-25-108893.md) | [343](/filings/0001193125-25-280175.md) | [361](/filings/0001193125-26-338354.md) | [356](/filings/0001193125-26-211875.md) | [372](/filings/0001193125-26-338354.md) |
| Long-term debt | $m | not reported | [436](/filings/0000950170-25-042774.md) | not reported | not reported | not reported | [267](/filings/0001193125-26-072181.md) | [310](/filings/0000950170-25-072774.md) | [317](/filings/0000950170-25-108893.md) | [307](/filings/0001193125-25-280175.md) | [314](/filings/0001193125-26-338354.md) | [313](/filings/0001193125-26-211875.md) | [329](/filings/0001193125-26-338354.md) |
| Shareholders' equity | $m | [217](/filings/0000950170-25-042774.md) | [0.0](/filings/0000950170-24-127114.md) | [192](/filings/0001193125-25-280175.md) | [186](/filings/0001193125-25-280175.md) | [0.0](/filings/0000950170-24-127114.md) | [325](/filings/0001193125-26-072181.md) | [325](/filings/0000950170-25-072774.md) | [370](/filings/0000950170-25-108893.md) | [385](/filings/0001193125-25-280175.md) | [391](/filings/0001193125-26-338354.md) | [418](/filings/0001193125-26-211875.md) | [437](/filings/0001193125-26-338354.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2.6](/filings/0000950170-25-072774.md) | [5.1 d](/filings/0000950170-25-108893.md) | [7.6 d](/filings/0001193125-25-280175.md) | [2.7](/filings/0001193125-26-072181.md) | [8.1](/filings/0001193125-26-211875.md) | [9.3 d](/filings/0001193125-26-338354.md) | [8.3 d](/filings/0001193125-25-280175.md) | [16.5 d](/filings/0001193125-26-072181.md) | [7.1](/filings/0001193125-26-211875.md) | [11.4 d](/filings/0001193125-26-338354.md) |
| Dividends paid | $m | not reported | not reported | [0.0 d](/filings/0001193125-25-280175.md) | not reported | [3.8](/filings/0001193125-26-211875.md) | [3.8 d](/filings/0001193125-26-338354.md) | [4.4 d](/filings/0001193125-25-280175.md) | [4.6 d](/filings/0001193125-26-072181.md) | [4.8](/filings/0001193125-26-211875.md) | [4.8 d](/filings/0001193125-26-338354.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q4 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [27.6](/filings/0001193125-26-072181.md) | [17.3](/filings/0001193125-26-211875.md) | [19.1](/filings/0001193125-26-338354.md) | [27.8](/filings/0001193125-25-280175.md) | [22.3](/filings/0001193125-26-211875.md) | [23.1](/filings/0001193125-26-338354.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,455,953 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-338354.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.